Sol-Gel Technologies (SLGL) Non-cash Items (2016 - 2020)
Sol-Gel Technologies (SLGL) reported Non-cash Items of $2.1 million for Q4 2020, down 5.85% year-over-year from $2.3 million in Q1 2020, and down 5.85% quarter-over-quarter from $2.3 million in Q4 2019.
Sol-Gel Technologies (SLGL) Non-cash Items (2016 - 2020) Analysis & Trends
Sol-Gel Technologies (SLGL) has 5 years of Non-cash Items data on file, last reported at $2.1 million in Q4 2020.
- Non-cash Items for Q4 2020 came in at $2.1 million, down 5.85% year-over-year; the trailing twelve-month figure through Dec 2020 was $2.1 million (down 5.85% YoY), and the FY2020 annual result was $2.1 million, down 5.85% from the prior year.
- Non-cash Items fell to $2.1 million in Q4 2020 per SLGL's latest filing, from $2.3 million in the prior quarter.
- Over five years, Non-cash Items peaked at $2.3 million in Q4 2019 and troughed at $7614.0 in Q4 2017.
- A 5-year average of $931549.0 and a median of $192338.0 in 2016 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2017 and 2019: Non-cash Items tumbled 96.04% in 2017, then surged 4974.45% in 2019.
- A 5-year view of Non-cash Items shows it stood at $192338.0 in 2016, then plunged by 96.04% to $7614.0 in 2017, then soared by 488.3% to $44793.0 in 2018, then surged by 4974.45% to $2.3 million in 2019, then fell by 5.85% to $2.1 million in 2020.
- Business Quant data shows SLGL's Non-cash Items at $2.1 million in Q4 2020, $2.3 million in Q4 2019, and $44793.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.14 Mn |
| Dec 31, 2020 | 2.14 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Dec 31, 2018 | 44,793.00 |
| Dec 31, 2018 | 44,793.00 |
| Dec 31, 2017 | 7,614.00 |
| Dec 31, 2017 | 7,614.00 |
| Dec 31, 2016 | 192,338.00 |
| Dec 31, 2016 | 192,338.00 |